Get the Stockscreener App
0.6746
2.99%
-0.0208
After Hours:
.69
0.0154
+2.28%
Tenaya Therapeutics Inc stock is traded at $0.6746, with a volume of 863.07K.
It is down -2.99% in the last 24 hours and up +10.25% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$0.6954
Open:
$0.6954
24h Volume:
863.07K
Relative Volume:
0.36
Market Cap:
$109.74M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-0.5111
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
-8.13%
1M Performance:
+10.25%
6M Performance:
-32.54%
1Y Performance:
-75.01%
1-Day Range:
$0.6705
$0.715
1-Week Range:
$0.6423
$0.74
52-Week Range:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.6746 | 113.12M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.65 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.13 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.14 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.15 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
298.52 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Tenaya Therapeutics Posts Smaller Losses And Advances Gene Trials - Finimize
Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Tenaya's Gene Therapies Clear Key Safety Hurdles: Q4 Data Readouts Coming for Heart Disease Treatments - Stock Titan
What are the technical indicators suggesting about Tenaya Therapeutics Inc.Achieve consistent profits with proven methods - Jammu Links News
What analysts say about Tenaya Therapeutics Inc. stockPhenomenal wealth increase - Jammu Links News
Why is Tenaya Therapeutics Inc. stock attracting strong analyst attentionCapitalize on fast-moving stock opportunities - Jammu Links News
How strong is Tenaya Therapeutics Inc. company’s balance sheetMaximize your gains with professional insights - Jammu Links News
Does Tenaya Therapeutics Inc. stock perform well during market downturnsMarket-beating returns - Jammu Links News
What are the latest earnings results for Tenaya Therapeutics Inc.Market-leading capital gains - Jammu Links News
What is Tenaya Therapeutics Inc. company’s growth strategyCapitalize on market shifts before others do - Jammu Links News
What makes Tenaya Therapeutics Inc. stock price move sharplyMaximize gains with timely market signals - Jammu Links News
What is the dividend policy of Tenaya Therapeutics Inc. stockBoost your wealth with consistent growth stocks - Jammu Links News
How sentiment analysis helps forecast Tenaya Therapeutics Inc.ROI Focused Setup Screener With Exit Markers - Newser
Can Tenaya Therapeutics Inc. hit a new high this monthMarket Opportunity Tracker for Swing Traders - Newser
Is Tenaya Therapeutics Inc. stock bottoming outVolume Confirmed Setup with Entry Confidence - Newser
How to read the order book for Tenaya Therapeutics Inc.Free Consistent Profit Pattern Recognition Tools - Newser
Advanced analytics toolkit walkthrough for Tenaya Therapeutics Inc.Technical Confirmation System with Signal Alerts - Newser
How does Tenaya Therapeutics Inc. generate profit in a changing economyChart Pattern Strategy To Watch Now - Jammu Links News
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of “Buy” from Analysts - Defense World
Using economic indicators to assess Tenaya Therapeutics Inc. potentialReal Market Tracker with Price Action Tools - Newser
Will Tenaya Therapeutics Inc. stock go up soonFundamental Forecast for Undervalued Stocks - Newser
What institutions are buying Tenaya Therapeutics Inc. stock nowFundamental Forecast for Undervalued Stocks - Newser
Intrinsic Value of Tenaya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedDaily Breakout List with Smart Filters - Newser
Kalaris Therapeutics shares rise 1.49% intraday after Tenaya Therapeutics, Inc. received positive safety endorsements for its cardiovascular gene therapy clinical trials. - AInvest
Published on: 2025-07-30 22:05:21 - metal.it
Tenaya Receives Positive Safety Reviews from Independent - GlobeNewswire
Tenaya Therapeutics stock rises after positive safety reviews for heart gene therapies By Investing.com - Investing.com South Africa
Tenaya Therapeutics stock rises after positive safety reviews for heart gene therapies - Investing.com Nigeria
Gene Therapy's Cardiovascular Revolution: Why Tenaya Therapeutics Is a High-Conviction Bet in 2025 - AInvest
Tenaya completes enrollment in both dose cohorts for HCM gene therapy - Investing.com
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed - The Manila Times
Breakthrough: Tenaya's Dual Heart Disease Gene Therapies Pass Major Safety Milestone - Stock Titan
How Resilient Is Tenaya Therapeutics Inc. Stock During Economic DownturnsEarly Buy Opportunity with Chart Triggers - Newser
Will earnings trigger a reversal in Tenaya Therapeutics Inc.Real-Time AI Entry Forecast Generator - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookEntry Optimization Tool with Screener Logic - Newser
Analyzing net buyer seller activity in Tenaya Therapeutics Inc.Free Reversal Alert Based on RSI Indicator - Newser
Is it the right time to buy Tenaya Therapeutics Inc. stockEarnings Report Insights With Low Risk - jammulinksnews.com
How Tenaya Therapeutics Inc. stock performs during market volatilityFree AI Screening for Swing Trade Picks - Newser
Is Tenaya Therapeutics Inc. forming a reversal patternInvestment Life Cycle Planning Summary - Newser
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):